X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (85) 85
index medicus (73) 73
life sciences (60) 60
male (48) 48
female (45) 45
middle aged (45) 45
urology & nephrology (45) 45
immunology (42) 42
[ sdv.imm ] life sciences [q-bio]/immunology (35) 35
aged (31) 31
mesh : humans (28) 28
adult (24) 24
amyloidosis (23) 23
bortezomib (20) 20
multiple myeloma (20) 20
transplantation (19) 19
dexamethasone (18) 18
retrospective studies (18) 18
treatment outcome (18) 18
al amyloidosis (17) 17
glomerulonephritis (17) 17
biopsy (14) 14
hematology (14) 14
immunoglobulins (14) 14
prognosis (14) 14
abridged index medicus (13) 13
chemotherapy (13) 13
fanconi syndrome (13) 13
kidney diseases (13) 13
kidney diseases - pathology (13) 13
multiple-myeloma (13) 13
aged, 80 and over (12) 12
hemodialysis (12) 12
immunoglobulin light chains (12) 12
mesh : female (12) 12
mesh : male (12) 12
mesh : middle aged (12) 12
stem-cell transplantation (12) 12
animals (11) 11
human health and pathology (11) 11
kidney diseases - etiology (11) 11
kidney diseases - immunology (11) 11
monoclonal gammopathy (11) 11
multiple myeloma - complications (11) 11
paraproteinemias - complications (11) 11
drug therapy, combination (10) 10
kidney - pathology (10) 10
kidney transplantation (10) 10
[sdv.imm] life sciences [q-bio]/immunology (9) 9
acute kidney injury (9) 9
cryoglobulinemia - complications (9) 9
diagnosis (9) 9
disease (9) 9
france (9) 9
free light-chains (9) 9
medicine, general & internal (9) 9
nephrology (9) 9
paraproteinemias (9) 9
research (9) 9
cancer (8) 8
cyclophosphamide (8) 8
dexamethasone - administration & dosage (8) 8
fanconi syndrome - etiology (8) 8
follow-up studies (8) 8
kidney (8) 8
kidney failure, chronic - etiology (8) 8
melphalan (8) 8
mesh : aged (8) 8
mesh : amyloidosis (8) 8
mesh : fanconi syndrome (8) 8
myeloma (8) 8
survival (8) 8
time factors (8) 8
[ sdv ] life sciences [q-bio] (7) 7
[sdv]life sciences [q-bio] (7) 7
acute kidney injury - etiology (7) 7
cryoglobulinemia (7) 7
free light chains (7) 7
glomerulonephritis - pathology (7) 7
kaplan-meier estimate (7) 7
light-chain amyloidosis (7) 7
membranoproliferative glomerulonephritis (7) 7
mesh : immunoglobulin light chains (7) 7
mesh : paraproteinemias (7) 7
mesh: humans (7) 7
mice (7) 7
paraproteinemias - immunology (7) 7
primary systemic amyloidosis (7) 7
[sdv.imm]life sciences [q-bio]/immunology (6) 6
acute-renal-failure (6) 6
amino acid sequence (6) 6
amyloidosis - therapy (6) 6
boronic acids - therapeutic use (6) 6
combined modality therapy (6) 6
deposition disease (6) 6
dexamethasone - therapeutic use (6) 6
failure (6) 6
fibrillary glomerulonephritis (6) 6
gastroenterology & hepatology (6) 6
glomerulonephritis - immunology (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Néphrologie & Thérapeutique, ISSN 1769-7255, 04/2019, Volume 15, pp. S115 - S121
Journal Article
Nephrologie et Thérapeutique, ISSN 1769-7255, 04/2019, Volume 15, pp. S115 - S121
The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the... 
Journal Article
Orphanet Journal of Rare Diseases, ISSN 1750-1172, 2012, Volume 7, Issue 1, pp. 54 - 54
Journal Article
Nephrologie et Therapeutique, ISSN 1769-7255, 2019
AL amyloidosis is caused by the conversion of monoclonal immunoglobulin light chains into amyloid fibrillar aggregates that deposit in tissue and lead to organ... 
AL amyloidosis | Cyclophosphamide | Bortezomib | Dexamethasone | Treatment | Haematologic response | Melphalan | Free light chains
Journal Article
Journal Article
Nephrologie & therapeutique, 04/2019, Volume 15 Suppl 1, p. S115
The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the... 
Journal Article
Kidney International, ISSN 0085-2538, 09/2017, Volume 92, Issue 3, pp. 766 - 766
Journal Article
Kidney International, ISSN 0085-2538, 09/2017, Volume 92, Issue 3, p. 766
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2007, Volume 357, Issue 11, pp. 1083 - 1093
Journal Article
Kidney International, ISSN 0085-2538, 10/2014, Volume 86, Issue 4, pp. 669 - 671
AL amyloidosis is a severe complication of plasma-cell disorders, secondary to monoclonal immunoglobulin light chain (LC) deposition in the kidney and other... 
UROLOGY & NEPHROLOGY | NEPHROPATHY | FANCONI SYNDROME | Animals | Immunoglobulin Light Chains - pharmacology | Glomerular Mesangium - metabolism | Amyloid - biosynthesis | Male | Lysosomes - physiology | Amyloidosis - metabolism | Disease Models, Animal | Kidney Diseases - metabolism
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 09/2019
Abstract Proliferative glomerulonephritis (GN) with monoclonal immunoglobulin deposits (PGNMIDs) is a recently described entity among the spectrum of... 
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 06/2019, Volume 34, Issue Supplement_1
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 22, pp. 4292 - 4295
Journal Article
JAMA, ISSN 0098-7484, 12/2017, Volume 318, Issue 21, pp. 2099 - 2110
Journal Article
Kidney International, ISSN 0085-2538, 11/2015, Volume 88, Issue 5, pp. 1135 - 1143
Monoclonal immunoglobulin deposition disease (MIDD) is a rare complication of plasma cell disorders, defined by linear Congo red-negative deposits of... 
monoclonalimmunoglobulin | free light chains | bortezomib | monoclonalgammopathy of renal significance | monodonalimmunoglobulir deposition disease | Monoclonal gammopathy of renal significance | Free light chains | Bortezomib | Monoclonal immunoglobulin deposition disease | Monoclonal immunoglobulin | MULTIPLE-MYELOMA | DEXAMETHASONE | CYCLOPHOSPHAMIDE | monoclonal gammopathy of renal significance | CHEMOTHERAPY | IMPAIRMENT | monoclonal immunoglobulin deposition disease | GAMMOPATHY | monoclonal immunoglobulin | LIGHT-CHAIN AMYLOIDOSIS | UROLOGY & NEPHROLOGY | REVERSIBILITY | STEM-CELL TRANSPLANTATION | AL AMYLOIDOSIS | Kidney Diseases - physiopathology | Cyclophosphamide - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Thalidomide - analogs & derivatives | Glomerular Filtration Rate - drug effects | Multiple Myeloma - drug therapy | Waldenstrom Macroglobulinemia - drug therapy | Waldenstrom Macroglobulinemia - complications | Female | Retrospective Studies | Multiple Myeloma - blood | Waldenstrom Macroglobulinemia - blood | Glomerular Basement Membrane - metabolism | Dexamethasone - administration & dosage | Kidney Diseases - pathology | Multiple Myeloma - complications | Survival Rate | Thalidomide - administration & dosage | Disease Progression | Immunoglobulin Light Chains - metabolism | Kidney Diseases - immunology | Proteinuria - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Bortezomib - therapeutic use | Immunoglobulin Heavy Chains - metabolism | Aged
Journal Article
Journal Article